STOCK TITAN

AbbVie Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

AbbVie (NYSE:ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on November 14, 2025, to stockholders of record as of October 15, 2025. The company has demonstrated strong commitment to shareholder returns, increasing its dividend by 310 percent since its inception in 2013.

As a member of the S&P Dividend Aristocrats Index, AbbVie has maintained a track record of consistently increasing its dividend for at least 25 consecutive years, highlighting its financial stability and dedication to shareholder value.

AbbVie (NYSE:ABBV) ha comunicato un dividendo in contanti trimestrale di $1,64 per azione, pagabile il 14 novembre 2025 agli azionisti registrati al 15 ottobre 2025. L'azienda ha mostrato un forte impegno verso la remunerazione degli azionisti, avendo aumentato il dividendo del 310 percento dall'avvio nel 2013.

Membro dell'S&P Dividend Aristocrats Index, AbbVie ha incrementato il dividendo per almeno 25 anni consecutivi, a testimonianza della sua stabilità finanziaria e dell'attenzione al valore per gli azionisti.

AbbVie (NYSE:ABBV) anunció un dividendo trimestral en efectivo de $1.64 por acción, pagadero el 14 de noviembre de 2025 a los accionistas registrados al 15 de octubre de 2025. La compañía ha mostrado un sólido compromiso con la retribución a los accionistas, aumentando su dividendo en un 310 por ciento desde su inicio en 2013.

Como miembro del S&P Dividend Aristocrats Index, AbbVie ha mantenido la política de incrementar su dividendo durante al menos 25 años consecutivos, lo que evidencia su estabilidad financiera y dedicación al valor para los accionistas.

AbbVie (NYSE:ABBV)는 주당 $1.64의 분기 현금 배당을 발표했으며, 이는 2025년 10월 15일 기준 주주에게 2025년 11월 14일에 지급됩니다. 회사는 2013년 시작 이래 배당금을 310퍼센트 인상하며 주주 환원에 강한 의지를 보여왔습니다.

S&P Dividend Aristocrats Index 회원사로서 AbbVie는 최소 25년 연속으로 배당을 증가시켜 왔으며, 이는 재무 안정성과 주주가치에 대한 헌신을 나타냅니다.

AbbVie (NYSE:ABBV) a annoncé un dividende trimestriel en numéraire de 1,64 $ par action, payable le 14 novembre 2025 aux actionnaires inscrits au 15 octobre 2025. La société manifeste un fort engagement envers la rémunération des actionnaires, ayant augmenté son dividende de 310 % depuis sa création en 2013.

Membre du S&P Dividend Aristocrats Index, AbbVie a relevé son dividende pendant au moins 25 années consécutives, ce qui témoigne de sa stabilité financière et de son attention portée à la valeur pour les actionnaires.

AbbVie (NYSE:ABBV) hat eine vierteljährliche Bardividende von $1,64 pro Aktie angekündigt, zahlbar am 14. November 2025 an die am 15. Oktober 2025 eingetragenen Aktionäre. Das Unternehmen zeigt ein starkes Bekenntnis zur Aktionärsrendite und hat seine Dividende seit 2013 um 310 Prozent erhöht.

Als Mitglied des S&P Dividend Aristocrats Index erhöht AbbVie die Dividende seit mindestens 25 aufeinanderfolgenden Jahren, was seine finanzielle Stabilität und die Fokussierung auf Aktionärswert unterstreicht.

Positive
  • Quarterly dividend of $1.64 per share maintained
  • 310% dividend increase since 2013
  • Member of S&P Dividend Aristocrats Index, showing consistent dividend growth
Negative
  • None.

NORTH CHICAGO, Ill., Sept. 5, 2025 The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share.  

The cash dividend is payable November 14, 2025, to stockholders of record at the close of business on October 15, 2025. 

Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube. 

Media:

Gabby Tarbert

(224) 244-0111

Investors:

Liz Shea
(847) 935-2211

gabrielle.tarbert@abbvie.com

liz.shea@abbvie.com

AbbVie logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302547709.html

SOURCE AbbVie

FAQ

When will AbbVie (ABBV) pay its next dividend?

AbbVie will pay its quarterly dividend of $1.64 per share on November 14, 2025, to stockholders of record as of October 15, 2025.

What is the dividend amount for AbbVie stock?

AbbVie's quarterly dividend is $1.64 per share, representing a 310% increase since the company's inception in 2013.

Is AbbVie (ABBV) a Dividend Aristocrat?

Yes, AbbVie is a member of the S&P Dividend Aristocrats Index, which includes companies that have increased their dividend annually for at least 25 consecutive years.

How much has AbbVie's dividend grown since 2013?

AbbVie has increased its dividend by 310 percent since its inception in 2013, demonstrating strong commitment to shareholder returns.
Abbvie Inc

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Latest SEC Filings

ABBV Stock Data

374.26B
1.76B
0.1%
74.56%
0.86%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NORTH CHICAGO